Literature DB >> 31350803

Quality-Adjusted Life-Years Lost Due to Physical Inactivity in the United States Osteoarthritis Population.

Elena Losina1,2,3,4, Genevieve S Silva1, Karen C Smith1, Jamie E Collins1,2, David J Hunter5, Swastina Shrestha1, Stephen P Messier6, Ed H Yelin7, Lisa G Suter8,9, A David Paltiel10, Jeffrey N Katz1,2,3.   

Abstract

OBJECTIVE: Half of the 14 million persons in the US with knee osteoarthritis (OA) are not physically active, despite evidence that physical activity (PA) is associated with improved health. We estimated both the quality-adjusted life-year (QALY) losses in the US knee OA population due to physical inactivity and the health benefits associated with higher PA levels.
METHODS: We used data from the Osteoarthritis Initiative and CDC to estimate the proportions of the US knee OA population aged 45+ that are inactive, insufficiently active, and active and their likelihoods of shifting PA level. We used the Osteoarthritis Policy (OAPol) Model, a computer simulation of knee OA, to determine QALYs lost due to inactivity and to measure potential benefits (comorbidities averted and QALYs saved) of increased PA.
RESULTS: Among 13.7 million persons living with knee OA, 7.5 million total QALYs, or 0.55 QALYs/person, were lost due to inactivity or insufficient PA relative to activity over their remaining lifetimes. Black Hispanic women experienced the highest losses, 0.76 QALYs/person. Females of all races/ethnicities had ~20% higher loss burdens than males. According to our model, if 20% of the inactive population were instead active, 95,920, 222,413, and 214,725 potential cases of cancer, cardiovascular disease, and diabetes would be averted, and 871,541 potential QALYs would be saved.
CONCLUSION: Physical inactivity leads to substantial QALY losses in the US knee OA population. Increasing activity level in even a fraction of this population may have considerable collateral health benefits, potentially averting cases of cancer, cardiovascular disease, and diabetes. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

Entities:  

Year:  2019        PMID: 31350803     DOI: 10.1002/acr.24035

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  7 in total

1.  Long-term clinical and economic outcomes of a short-term physical activity program in knee osteoarthritis patients.

Authors:  G S Silva; J K Sullivan; J N Katz; S P Messier; D J Hunter; E Losina
Journal:  Osteoarthritis Cartilage       Date:  2020-03-10       Impact factor: 6.576

Review 2.  Moving toward targeting the right phenotype with the right platelet-rich plasma (PRP) formulation for knee osteoarthritis.

Authors:  Isabel Andia; Leire Atilano; Nicola Maffulli
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-03-29       Impact factor: 5.346

3.  Does Screening for Depressive Symptoms Help Optimize Duloxetine Use in Knee Osteoarthritis Patients With Moderate Pain? A Cost-Effectiveness Analysis.

Authors:  Nora K Lenhard; James K Sullivan; Eric L Ross; Shuang Song; Robert R Edwards; David J Hunter; Tuhina Neogi; Jeffrey N Katz; Elena Losina
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-03-29       Impact factor: 5.178

4.  A comparison of three strategies to reduce the burden of osteoarthritis: A population-based microsimulation study.

Authors:  Jacek A Kopec; Eric C Sayre; Anya Okhmatovskaia; Jolanda Cibere; Linda C Li; Nick Bansback; Hubert Wong; Shahzad Ghanbarian; John M Esdaile
Journal:  PLoS One       Date:  2021-12-08       Impact factor: 3.240

5.  Racial and Socioeconomic Disparities in the Utilization of TKA Among Patients with Posttraumatic Knee Osteoarthritis: Estimates from the United States National Inpatient Sample, 2011-2018.

Authors:  Joseph Atarere; Emeka Agudile; Vwaire Orhurhu; Ukamaka M Agudile; George Sorescu; Zakari Aliyu Suleiman; Michael J Weaver; Arvind Von Keudell
Journal:  JB JS Open Access       Date:  2022-09-14

6.  A tale of osteoarthritis among older adults during the COVID-19 pandemic in Bangladesh: A repeated cross-sectional study.

Authors:  Sabuj Kanti Mistry; A R M Mehrab Ali; Uday Narayan Yadav; Rajat Das Gupta; Afsana Anwar; Saurav Basu; Md Nazmul Huda; Dipak Kumar Mitra
Journal:  PLoS One       Date:  2022-09-20       Impact factor: 3.752

7.  Human placental extract: the feasibility of translation from basic science into clinical practice.

Authors:  Ahmed K Emara; Hiba Anis; Nicolas S Piuzzi
Journal:  Ann Transl Med       Date:  2020-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.